KIGABEQ 500 mg, tablet soluble 50 tablets
Active ingredients: Vigabatrin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet50 tabletsgastrique;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KIGABEQ 500 mg, comprimé soluble
- Pharmaceutical form
- comprimé
- Route of administration
- gastrique;orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 50 comprimés
- Marketing authorisation holder
- ORPHELIA PHARMA
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jun 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62674714CIP73015762CIP133400930157626Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIGABATRINEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.